LBi launches US digital health shop

Share this article:
BMS’s Reyataz “Fight HIV Your Way” photo contest was executed by the agency
BMS’s Reyataz “Fight HIV Your Way” photo contest was executed by the agency
LBi, a big European indie digital agency network, is opening up a healthcare marketing shop in the US, seeing opportunity in Publicis' increasing domination of the digital health space.

LBi Health will boast a staff of 70 working out of its New York headquarters and handling a roster of clients including Roche, Bayer, Bristol-Myers Squibb, J&J, AstraZeneca, Forest, Genzyme, WebMD, Massachusetts General Hospital and Mount Sinai.

LBi, a big independent network with roots in London and Scandinavia, has around 1,800 employees working out of 26 offices in 16 countries – mostly in Europe, though the company has made inroads into Asia-Pacific and North America in recent years. LBi US formed from a merger of IconNicholson and Special Ops Media two years back. The company has been quietly building up its US healthcare presence for more than a decade, having built the first consumer site for Viagra and seen 80% growth in its healthcare operations for each of the past four years.  

“With each successive wave of growth, we've brought on more resources, and we're now at a scale where it makes sense for us to become our own agency,” said Gregg Fisher, who will serve as managing director of LBi Health.

Fisher describes the firm's offering as that of a “multichannel healthcare marketing agency with roots in the digital world that set us apart.” The agency will handle consumer-and professional-focused assignments, bringing tech expertise and an ability to partner with other shops. Their motto is “Creating connections that matter between brands and customers.”

“Traditional agencies excel at messaging,” said Fisher. “What we're really good at is managing the entire customer journey and coordinating that across channels.”

LBi is betting that Publicis' recent acquisition of Rosetta, placing the digital shop under the same holding company as Digitas and Razorfish, will boost its business as clients sweat conflicts and seek out alternatives.

“The innovative sector of healthcare communications really doesn't have many independent shops that have the scale we have globally,” he says, adding that LBi has brought on “a lot of very talented people from Digitas” and other shops as a result of Publicis' recent roll-up.

Recent work by the firm includes BMS's Fight HIV Your Way contest for Reyataz and Yervoy professional launch.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...